CD82 and neoplasm: It appears that high tetraspanin levels, namely CD82 and CD9, are related to tumor growth inhibition, as studies have demonstrated that in some late-stage tumors, such as colorectal cancer, these tetraspanins are downregulated and therefore associated with poor prognosis [4].